Farther Finance Advisors, LLC Ventyx Biosciences, Inc. Transaction History
Farther Finance Advisors, LLC
- $2.06 Trillion
- Q2 2024
A detailed history of Farther Finance Advisors, LLC transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 1,295 shares of VTYX stock, worth $2,823. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,295
Previous 725
78.62%
Holding current value
$2,823
Previous $4.05 Million
27.78%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding VTYX
# of Institutions
124Shares Held
57.4MCall Options Held
222KPut Options Held
269K-
Deerfield Management Company, L.P. (Series C) New York, NY5.83MShares$12.7 Million0.28% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.76MShares$12.6 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA5.25MShares$11.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.77MShares$10.4 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.17MShares$6.91 Million0.04% of portfolio
About Ventyx Biosciences, Inc.
- Ticker VTYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,527,200
- Market Cap $123M
- Description
- Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...